Literature DB >> 8916158

High levels of cerebrospinal fluid glutamate in Rett syndrome.

R Lappalainen1, R S Riikonen.   

Abstract

Rett syndrome is a neurodevelopmental disease affecting girls. The cause is not known. Roles for trophic factors and excitatory neurotransmitters have been postulated. To study the significance of excitatory amino acids in Rett syndrome, we determined glutamate and aspartate concentrations in the cerebrospinal fluid from 11 girls with Rett syndrome (age 8 years 4 months +/- 5.7 years, mean +/- SD) and 11 controls (age 7 +/- 4.2 years). In the patients with Rett syndrome, the mean of cerebrospinal fluid glutamate concentration was 355.2 nmol/L (SD +/- 109.2 nmol/L). In the controls it was 203.9 nmol/L (SD +/- 55.5 nmol/L). In Rett syndrome cases, cerebrospinal fluid glutamate concentrations were significantly higher (P = 0.0006) than in the controls. In the Rett syndrome group, the mean cerebrospinal fluid aspartate concentration was 119.4 nmol/L (SD +/- 43.5 nmol/L). In the control group, it was 90.9 nmol/L (SD +/- 20.9 nmol/L). The difference between the cerebrospinal fluid aspartate values was not significant. Glutamate may therefore play an important role in the primary pathogenesis in Rett syndrome. Further investigations are needed, with recognition of possible actions of neuronal growth factors and excitatory neurotransmitters in the damage mechanisms of Rett syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916158     DOI: 10.1016/s0887-8994(96)00218-4

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  21 in total

Review 1.  Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory network.

Authors:  Michael Ogier; David M Katz
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

2.  Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate.

Authors:  Izumi Maezawa; Lee-Way Jin
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

Review 3.  Does microglial dysfunction play a role in autism and Rett syndrome?

Authors:  Izumi Maezawa; Marco Calafiore; Heike Wulff; Lee-Way Jin
Journal:  Neuron Glia Biol       Date:  2012-04-30

4.  Temporal and regional alterations in NMDA receptor expression in Mecp2-null mice.

Authors:  Mary E Blue; Walter E Kaufmann; Joseph Bressler; Charlotte Eyring; Cliona O'driscoll; Sakkubai Naidu; Michael V Johnston
Journal:  Anat Rec (Hoboken)       Date:  2011-09-08       Impact factor: 2.064

5.  Epigenetics and Neural developmental disorders: Washington DC, September 18 and 19, 2006.

Authors:  Xinyu Zhao; ChangHui Pak; Richard D Smrt; Peng Jin
Journal:  Epigenetics       Date:  2007-04-30       Impact factor: 4.528

6.  Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T.

Authors:  Gagan Joshi; Joseph Biederman; Janet Wozniak; Rachel L Goldin; Dave Crowley; Stephannie Furtak; Scott E Lukas; Atilla Gönenç
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-18       Impact factor: 5.270

7.  Insulinotropic treatments exacerbate metabolic syndrome in mice lacking MeCP2 function.

Authors:  Meagan R Pitcher; Christopher S Ward; E Melissa Arvide; Christopher A Chapleau; Lucas Pozzo-Miller; Andreas Hoeflich; Manaswini Sivaramakrishnan; Stefanie Saenger; Friedrich Metzger; Jeffrey L Neul
Journal:  Hum Mol Genet       Date:  2013-03-05       Impact factor: 6.150

Review 8.  Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders.

Authors:  Michael G Aman; Cristan A Farmer; Jill Hollway; L Eugene Arnold
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-10

9.  Brain metabolism in Rett syndrome: age, clinical, and genotype correlations.

Authors:  Alena Horská; Luciano Farage; Genila Bibat; Lídia M Nagae; Walter E Kaufmann; Peter B Barker; SakkuBai Naidu
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

10.  Randomized open-label trial of dextromethorphan in Rett syndrome.

Authors:  Constance L Smith-Hicks; Siddharth Gupta; Joshua B Ewen; Manisha Hong; Lisa Kratz; Richard Kelley; Elaine Tierney; Rebecca Vaurio; Genila Bibat; Abanti Sanyal; Gayane Yenokyan; Nga Brereton; Michael V Johnston; Sakkubai Naidu
Journal:  Neurology       Date:  2017-09-20       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.